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Integrin receptors play a central role in the biology of lymphocytes, mediating crucial
functional aspects of these cells, including adhesion, activation, polarization, migration,
and signaling. Here we report that induction of activation of the b2-integrin lymphocyte
function-associated antigen 1 (LFA-1) in T lymphocytes with divalent cations, phorbol
esters, or stimulatory antibodies is followed by a dramatic polarization, resulting in a
characteristic elongated morphology of the cells and the arrest of migrating lympho-
blasts. This cellular polarization was prevented by treatment of cells with the specific
tyrosine kinase inhibitor genistein. Furthermore, the interaction of the activated integrin
LFA-1 with its ligand intercellular adhesion molecule 1 induced the activation of the
cytoplasmic tyrosine kinases focal adhesion kinase (FAK) and proline-rich tyrosine
kinase 2 (PYK-2). FAK activation reached a maximum after 45 min of stimulation; in
contrast, PYK-2 activation peaked at 30 min, declining after 60 min. Upon polarization of
lymphoblasts, FAK and PYK-2 redistributed from a diffuse localization in the cytoplasm
to a region close to the microtubule-organizing center in these cells. FAK and PYK-2
activation was blocked when lymphoblasts were pretreated with actin and tubulin
cytoskeleton-interfering agents, indicating its cytoskeletal dependence. Our results dem-
onstrate that interaction of the b2-integrin LFA-1 with its ligand intercellular adhesion
molecule 1 induces remodeling of T lymphocyte morphology and activation and redis-
tribution of the cytoplasmic tyrosine kinases FAK and PYK-2.
INTRODUCTION
Integrins are heterodimeric cell surface proteins that
function in cell adhesion, cytoskeleton anchorage, and
the transduction of cellular stimuli into cytoplasmic
signals (Clark and Brugge, 1995; Schwartz et al., 1995).
The b2-integrin lymphocyte function-associated anti-
gen 1 (LFA-1; CD11a/CD18) is selectively expressed
on leukocytes and mediates important adhesive phe-
nomena of these cells through interaction with its
ligands intercellular adhesion molecule 1 (ICAM-1;
CD54), ICAM-2 (CD102), and ICAM-3 (CD50). The
resting leukocytes, which circulate in the bloodstream,
express an inactive form of LFA-1 that is functionally
unable to mediate interactions with ICAMs. Induction
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of leukocyte activation through different cell surface
receptors, including the T cell receptor–CD3 complex
and receptors for cytokines, results in the generation
of intracellular signals that lead to activation of LFA-1
molecules. This “inside-out” mechanism of LFA-1 ac-
tivation brings about a change in the conformation of
the extracellular region of the integrin, which is func-
tionally reflected by the ability of the cells to adhere to
LFA-1 ligands. Activation of LFA-1 molecules can also
be induced directly from outside the cells by altering
the extracellular divalent cation conditions, i.e. by ad-
dition of micromolar concentrations of Mn21 or by the
presence of millimolar levels of Mg21 when Ca21 is
removed with EGTA (Dransfield et al., 1992a). Direct
activation of LFA-1 from outside the cells can also be
achieved with specific “activating” or “stimulating”
mAbs. These types of antibodies recognize and bind to
the a or the b subunits of LFA-1, altering the confor-
mation of the integrin to a state of increased affinity for
its ligands. Activating LFA-1 antibodies include NKI-
L16, which is specific for the a subunit or CD11a, and
KIM-127 and KIM-185, which are directed to the com-
mon b2 subunit CD18 (van Kooyk et al., 1991; Ortlepp
et al., 1995; Stephens et al., 1995). Phorbol esters such as
phorbol-12,13-dibutyrate (PDBu), which are potent
and sustained activators of PKC, have also been used
extensively as another means of inducing LFA-1–me-
diated adhesion to ICAMs (Rothlein and Springer,
1986; Stewart et al., 1996).
Upon ligand engagement of LFA-1, a variety of
intracellular signals are generated in T lymphocytes,
including phosphorylation of phospholipase Cg1,
phospholipid hydrolysis, activation of different isoen-
zymes of PKC, mobilization of intracellular Ca21, and
activation of tyrosine kinases (Wacholtz et al., 1989;
Kanner et al., 1993; Arroyo et al., 1994; Lub et al., 1995).
The focal adhesion kinase (FAK) is a nonreceptor pro-
tein-tyrosine kinase that colocalizes to cellular focal
adhesions with integrins (Hanks et al., 1992; Schaller et
al., 1992). FAK, one of the major substrates for inte-
grin-dependent tyrosine phosphorylation, is consid-
ered an important element in an integrin-regulated
pathway (Clark and Brugge, 1995; Richardson and
Parsons, 1995; Otey, 1996; Hanks and Polte, 1997).
FAK is tyrosine phosphorylated upon stimulation of
b1-integrins in fibroblasts, epidermal carcinoma cells,
mast cells, and T lymphocytes; upon engagement of
b3-integrin in platelets and upon transfection of hu-
man fibroblasts with chimeric receptors containing
either the b1-, b3-, or b5-integrin intracellular domain
(Kornberg et al., 1991; Guan and Shalloway, 1992;
Lipfert et al., 1992; Hamawy et al., 1993; Akiyama et al.,
1994; Matsumoto et al., 1994; Shattil et al., 1994; Magu-
ire et al., 1995). Concomitant with tyrosine phosphor-
ylation, FAK becomes enzymatically active (Guan and
Shalloway, 1992; Lipfert et al., 1992; Otey, 1996). A
variety of studies, including the characterization of
cells derived from FAK(2/2) embryos, suggests that
FAK may be involved in the regulation of cell spread-
ing and motility (Gates et al., 1994; Akasaka et al., 1995;
Ilic et al., 1995; Cary et al., 1996; Gilmore and Romer,
1996; Richardson and Parsons, 1996).
A second member of the FAK nonreceptor tyrosine
kinase family, known as proline-rich tyrosine kinase 2
(PYK-2), and also called related adhesion focal ty-
rosine kinase, cell adhesion kinase b, calcium-depen-
dent tyrosine kinase, or FAK2, has been described
(Avraham et al., 1995; Earp et al., 1995; Lev et al., 1995;
Sasaki et al., 1995; Herzog et al., 1996). PYK-2 is less
evenly expressed in tissues and restricted to a lower
number of cell types compared with FAK; however,
the expression is high in cells of neural, epithelial, or
hematopoetic origin (Avraham et al., 1995; Lev et al.,
1995; Yu et al., 1996). PYK-2 shares significant homol-
ogy with FAK (60% identity in the central catalytic
domain and 40% identity in both C and N termini)
and, like FAK, does not contain Src homology 2 (SH2)
or SH3 domains but contains several sites for binding
of SH2- and SH3-containing signaling proteins. Regu-
lation of PYK-2 localization and tyrosine phosphory-
lation seems to be cell type and integrin specific.
PYK-2 localizes to focal contacts and displays a b1-in-
tegrin–dependent phosphorylation in natural killer
cells, B lymphocytes, megakaryocytes and transfected
COS cells and exhibits a b3-dependent tyrosine phos-
phorylation in T lymphocytes (Li et al., 1996; Astier et
al., 1997; Gismondi et al., 1997; Ma et al., 1997). How-
ever, PYK-2 was localized to intercellular junctions
and was not tyrosine phosphorylated upon adhesion
of transfected 3Y1 fibroblasts on fibronectin or integrin
ligation during platelet aggregation (Sasaki et al., 1995;
Raja et al., 1997). It has been suggested that the differ-
ences in localization and tyrosine phosphorylation of
FAK and PYK-2 may be due to differences in the
sequences of the C termini of FAK and PYK-2 (Zheng
et al., 1998). Several studies suggest that PYK-2 may be
involved in the control of apoptosis and the regulation
of ion channels in neuronal cells (Lev et al., 1995; Xiong
and Parsons, 1997).
After activation and autophosphorylation of FAK
and PYK-2, these enzymes may serve as recruiting
molecules for various signaling and cytoskeletal pro-
teins, including the tyrosine kinases Src and Fyn, and
the focal contact proteins paxillin and p130Cas, which
are also potential targets for FAK and PYK-2 phos-
phorylation (Richardson and Parsons, 1995; Dikic et
al., 1996; Astier et al., 1997; Ganju et al., 1997; Gismondi
et al., 1997; Hanks and Polte, 1997; Hiregowdara et al.,
1997; Ohba et al., 1998; Schlaepfer and Hunter, 1998).
Therefore, integrin signaling, involving the activation
of FAK and PYK-2, has also been suggested to mod-
ulate the reorganization of the actin cytoskeleton and
to regulate changes in cell morphology. Polarization is
a key feature in the biology of T cells (Wilkinson and
J.L. Rodrı´guez-Ferna´ndez et al.
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Higgins, 1987; del Pozo et al., 1996; Sa´nchez-Madrid
and del Pozo, 1999). Lymphocytes acquire a polarized
phenotype after activation, upon interaction with an-
tigen-presenting cells (APCs) and during chemokine-
directed transendothelial migration. The leukocyte in-
tegrin LFA-1 plays a key role in these crucial events of
immune and inflammatory responses (Springer, 1990;
Dransfield et al., 1992a). Furthermore, cell polarization
in lymphocytes involves a reorganization of the cy-
toskeleton, including polymerization and redistribu-
tion of actin and reorientation of the microtubule-
organizing center (MTOC) toward the opposing cell
(Singer, 1992; Dustin et al., 1997; Lowin-Kropf et al.,
1998).
In this study we have analyzed some of the mor-
phological and functional changes that occur in T
lymphocytes after induction of activation of the inte-
grin LFA-1 and its interaction with its ligand ICAM-1.
We demonstrate that functional activation of LFA-1
brings about dramatic changes in the morphology and
polarization of these cells, converting them into a non-
motile phenotype. We also demonstrate, for the first
time, that concomitantly with these changes, the two
homologous cytoplasmic tyrosine kinases FAK and
PYK-2 become activated and redistributed intracellu-
larly, colocalizing in the polarized T cell with the
MTOC.
MATERIALS AND METHODS
Cells
Human T lymphoblasts were prepared from peripheral blood
mononuclear cells by treatment with 0.5% phytohemagglutinin for
48 h. Cells were washed and cultured in RPMI 1640 (Flow Labora-
tories, Irvine, Scotland) containing 10% FCS (Flow Laboratories) and
interleukin 2 (20 U/ml). T lymphoblasts cultured by 7–12 d were
typically used in all experiments (Dransfield et al., 1992b; Luque et
al., 1996; Stewart et al., 1996).
Antibodies and Reagents
A dimeric form of an ICAM-1-Fc chimeric protein consisting of the
five domains of ICAM-1 fused to the Fc fragment of human IgG1
was prepared as previously described (Berendt et al., 1992). The
LFA-1–stimulatory mAb KIM-127, which is specific for the b2-inte-
grin subunit (Ortlepp et al., 1995; Stephens et al., 1995) was a gen-
erous gift of Dr. Martyn Robinson (Celltech, Slough, United King-
dom). FAK antipeptide polyclonal antibodies C-20 and A-17 and
PYK-2 antipeptide polyclonal antibodies C-19 and N-19 were from
Santa Cruz Biotechnology (Santa Cruz, CA). The anti-FAK C-20 and
A-17 polyclonal antibodies were raised against peptides corre-
sponding to amino acids 1033–1052 mapping at the C terminus and
amino acids 2–18 mapping at the N termini of human FAK, respec-
tively. The anti-PYK-2 polyclonal antibodies C-19 and N-19 were
raised against peptides corresponding to amino acids 990-1009,
mapping at the C terminus, and amino acids 2–20, mapping at the
amino terminus, of human PYK-2, respectively. The anti-Tyr(P)
PY20 and the anti-FAK a-FAK mAbs were from Transduction Lab-
oratories (Lexington, KY). The mAb a-FAK recognizes an epitope in
the kinase domain of FAK, corresponding to amino acids 354–533 of
the chicken protein. The anti-FAK mAb 2A7 was from Upstate
Biotechnology (Lake Placid, NY). The 2A7 mAb recognizes an
epitope in the C domain of FAK (Schaller et al., 1993). The anti-
Tyr(P) mAb clone PY72 was obtained from the Hybridoma Devel-
opment Unit, Imperial Cancer Research Fund. [g-32P]ATP (4000
Ci/mmol) and l-[35S]methionine (400 Ci/mmol) were from ICN
Biochemicals (Costa Mesa, CA). Phytohemagglutinin, BSA, poly
Glu:Tyr (4:1), poly-l-lysine, cytochalasin D, colchicine, the anti-a-
tubulin mAb, and the FITC- and TRITC-conjugated secondary an-
tibodies were all obtained from Sigma (St. Louis, MO). Protein
A-agarose and Protein G-agarose were from Boehringer Mannheim
(Mannheim, Germany). ECL reagents were from Amersham (Buck-
inghamshire, United Kingdom). Tyrosine kinases inhibitor genistein
was from Calbiochem-Novabiochem (Nottingham, United King-
dom). Interleukin 2 was from Eurocetus (Amsterdam, The Nether-
lands). Taxol was a kind gift from Dr. J.M. Andreu (Centro de
Investigaciones Biolo´gicas, Consejo Superior de Investigaciones Ci-
entı´ficas, Madrid, Spain). All other reagents used were of the purest
grade available.
Cell Attachment Assays
Cell adhesion assays were essentially performed as described else-
where (Dransfield et al., 1992b; Luque et al., 1996). Briefly, 96-well
flat-bottom plates were precoated overnight at 4°C with 6 mg/ml
ICAM-1-Fc in adhesion buffer (20 mM Tris-HCl and 150 mM NaCl,
pH 8.2), blocked with 1% BSA in adhesion buffer for 1 h at room
temperature, and then washed twice with RPMI 1640. In control
nonspecific adhesion experiments, wells were precoated overnight
at 4°C with 20 mg/ml poly-l-lysine in water. T lymphoblasts (3 3
105 cells per well) were then added to the wells containing or not the
relevant stimuli for LFA-1 activation. When Mg21-EGTA was used
to stimulate LFA-1, cells were washed in HEPES-NaCl buffer (20
mM HEPES, 150 mM NaCl, and 2 mg/ml glucose, pH 7.4) instead
of RPMI 1640 medium. After 20 min on ice, incubation of plates
continued for 60 min at 37°C. Plates were then washed gently four
times with prewarmed RPMI 1640, and bound cells were quanti-
tated by measuring the absorbance of wells at 540 nm after fixation
and staining with 0.5% crystal violet in 20% methanol.
Digital Confocal Microscopy
For immunofluorescence analysis, round glass coverslips (13 mm
diameter) were precoated with recombinant ICAM-1Fc protein and
blocked with 1% BSA as indicated above. T lymphoblasts were
washed twice in HEPES-NaCl buffer and allowed to adhere to the
ICAM-1Fc–coated coverslips for 60 min at 37°C. After two washes
in PBS, adherent cells were fixed in 3.7% formaldehyde in PBS for 10
min at room temperature and then permeabilized in 0.1% Triton
X-100 in PBS and 0.5% BSA. Cells were then incubated for 45 min
with rabbit anti-FAK (C-20 or A-17) or goat anti-PYK-2 (C-19 or
N-19) polyclonal antibodies. Cells were then extensively washed in
PBS and 0.5% BSA and incubated for 60 min with the corresponding
anti-goat or anti-rabbit FITC-conjugated secondary antibody. In
some experiments, the samples were washed again with PBS, dou-
ble stained with the anti-a-tubulin mAb for 60 min, and washed in
PBS and 0.5% BSA, followed by an incubation for 60 min with an
anti-mouse TRITC-conjugated secondary antibody. In the experi-
ments in which actin was stained, cells were fixed as above and then
treated with TRITC-conjugated phalloidin in PBS and 0.5% BSA for
20 min and washed extensively in PBS. Before mounting the sam-
ples for fluorescence microscopy, they were washed again with PBS
and distilled water. Confocal microscopy was performed using a
MRC-1000 confocal laser scanning system (Bio-Rad, Watford,
United Kingdom) connected to a Nikon (Tokyo, Japan) Diaphot 200
inverted microscope. Images of 20 serial vertical cellular sections
were acquired every 0.5 mm with the Bio-Rad COMOS graphical
user interface and software.
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Quantitative Time-Lapse Video Microscopy of T
Lymphoblast Motility
Plastic dishes (35 mm) were precoated with recombinant ICAM-1Fc
protein and blocked with BSA as indicated above. T lymphoblasts
were plated immediately before video recording in RPMI 1640
medium supplemented with 1% FCS in the presence or absence of
the relevant stimuli for LFA-1 activation. Time-lapse video films of
cells were generated as a sequence of individual digital images
(“frames”) that were obtained every 10 s for 2.30 h in an Zeiss
(Thornwood, NY) Axiovert 135 video microscope using the IP-Lab
Spectrum software (Signal Analytics, Vienna, VA). The cellular
random migration tracks, distances, and average speeds of individ-
ual cells for each experimental condition were obtained using the
Cell Tracking software extension for IP-Lab Spectrum developed by
Tim Hutton (Confocal Microscopy and Digital Image Unit, Imperial
Cancer Research Fund).
Immunoprecipitation
T lymphoblasts (100 3 106 or 2.5 3 106 cells to immunoprecipitate
FAK or PYK-2, respectively, unless otherwise stated) were washed
twice with RPMI 1640, plated on dishes coated with either BSA or
ICAM-1, and, after 15 min on ice, stimulated with 10 mg/ml mAb
KIM-127 for 60 min. The stimulation was terminated by solubilizing
the cells in 1 ml of ice-cold lysis buffer (10 mM Tris-HCl, pH 7.65, 5
mM EDTA, 50 mM NaCl, 30 mM sodium pyrophosphate, 50 mM
NaF, 2 mM sodium orthovanadate, 1% Triton X-100, 50 mg/ml
aprotinin, 50 mg/ml leupeptin, 5 mg/ml pepstatin, and 1 mM
PMSF). Lysates were clarified by centrifugation at 14,000 rpm for 10
min, and the pellets were discarded. After centrifugation, superna-
tants were transferred to fresh tubes, and proteins were immuno-
precipitated at 4°C overnight with either protein A-agarose–linked
rabbit polyclonal anti-FAK antibodies (C-20 or A-17) or protein
G-agarose–linked mAbs directed against FAK (2A7 or a-FAK mAbs)
or against Tyr(P) proteins (PY20 and PY72 mAbs) or protein G-
agarose–linked goat polyclonal anti-PYK-2 antibody (C-19). Immu-
noprecipitates were washed three times with lysis buffer and either
used for in vitro kinase reactions (see below) or extracted in 23
SDS-PAGE sample buffer (200 mM Tris-HCl, pH 6.8, 0.1 mM so-
dium orthovanadate, 1 mM EDTA, 6% SDS, 2 mM EDTA, 4%
2-mercaptoethanol, and 10% glycerol), by boiling 5 min, fraction-
ated by one-dimensional SDS PAGE, and further analyzed as de-
scribed in RESULTS and figure legends.
In Vitro Kinase Reactions
Reactions were performed as described (Rodrı´guez-Ferna´ndez and
Rozengurt, 1996, 1998). Briefly, immunoprecipitates were washed
and pelleted (2500 rpm 10 min in the cold) three times in lysis buffer
and twice with kinase buffer (20 mM HEPES and 3 mM MnCl2, pH
7.35). Pellets were dissolved in 40 ml of kinase buffer, and reactions
were started by adding 10 mCi of [g-32P]ATP. The reactions were
carried out at 30°C for 15 min and were stopped on ice by adding 10
mM EDTA. After the in vitro kinase reactions, the pellet were
washed in lysis buffer containing 10 mM EDTA, extracted for 5 min
at 95°C in 23 SDS-PAGE sample buffer, and analyzed by SDS-
PAGE. In some experiments poly-Glu-Tyr (4:1; 40 mg) was added to
the immunocomplexes. The incorporation of 32P label into poly-Glu-
Tyr (4:1) was stopped by removing the supernatant from the aga-
rose beads and adding 23 SDS-PAGE sample buffer. Samples were
then analyzed by SDS-PAGE and autoradiography. After fixing and
drying of the gels, autoradiography was performed at 280°C. Au-
toradiograms were analyzed using an Agfa (Mortsel, Belgium) Stu-
dio Scan IIsi scanner, and bands were quantified using the Bio-Rad
Molecular Analyst software.
Western Blotting
Cell lysis and immunoprecipitations were performed as described
above. After SDS-PAGE, proteins were transferred to Immobilon
membranes (Millipore, Bedford, MA) using a Bio-Rad SD Transblot.
Membranes were blocked using 3% nonfat dried milk in PBS, pH
7.2, and incubated for 2 h at 22°C with the polyclonal antibodies
anti-PYK-2 (C-19 or N-19), diluted 1:500 in PBS containing 3%
nonfat dried milk. After incubating membranes with HRP-conju-
gated secondary antibodies, immunoreactive bands were visualized
using ECL reagents.
Metabolic Labeling and Autoradiography
Cells were labeled overnight with l[35S]methionine at 100 mCi/ml
in methionine-free RPMI 1640 containing 5% FCS, as described
previously (Rodrı´guez-Ferna´ndez et al., 1992). Labeled proteins
were used to immunoprecipitate FAK with the C-20 antibody. After
immunoprecipitation and SDS-PAGE, the gels were soaked in
DMSO twice, for 30 min periods, followed by treatment with 19%
2,5-diphenyloxazole (PPO) in DMSO for 2 h. The DMSO-PPO was
removed, and the gels were thoroughly washed in water. Gels were
dried in a heated gel drier under vacuum and exposed to x-ray
films.
RESULTS
Morphological Changes in T Lymphoblasts after
Induction of Activation of Integrin LFA-1
In the absence of stimulation the majority of T lym-
phoblasts grow in suspension and remain as individ-
ual cells displaying a rounded appearance. Despite the
high expression of both the integrin LFA-1 and its
ligand ICAM-1 on the surface of these activated T
cells, they do not form large intercellular aggregates,
indicating that LFA-1 is in an inactive state unable to
mediate ligand interactions. When unstimulated T
lymphoblasts are allowed to adhere to immobilized
ligand ICAM-1, only a relatively low percentage of
these cells are able to attach (Figure 1A, CONTROL).
Induction of activation of LFA-1 molecules on T cells
using activating mAb KIM-127, Mg21-EGTA, or the
phorbol ester PDBu results in an important increase in
the percentage of cells adhering to ICAM-1 (Figure
1A). Interestingly, this augmented adhesion is accom-
panied by profound changes in the morphology of the
adherent T cells. The lymphoblasts changed from their
round and moderately spread morphology to an elon-
gated and highly spread phenotype, in which a cell
body and a long, and generally unique, cell projection
were clearly distinguishable (Figure 1B, ICAM-1).
Staining of polymerized actin revealed that after 1 h of
adhesion to ICAM-1, actin was redistributed and or-
ganized in a thin rim around the nucleus of the cell
and, more importantly, in the long cytoplasmic pro-
jection (Figure 1B, ICAM-1). Cells plated on poly-l-
lysine, both unstimulated and stimulated with mAb
KIM-127, attached and spread onto the dishes but did
not exhibit any important change in their morphology
(Figure 1B, PLL). These adhesion experiments under
static conditions, together with the staining of actin in
fixed cells, demonstrate that activation of LFA-1 in-
duces important changes in the adhesion and mor-
phology of T lymphocytes.
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Figure 1. Agents that activate LFA-1 inte-
grin cause an increment in adhesion and po-
larization of lymphoblasts. (A) T lympho-
blasts plated on ICAM-1-Fc–coated plastic
dishes were allowed to adhere for 60 min in
the absence (CONTROL) or the presence of
different of LFA-1–activating agents: 10
mg/ml mAb KIM-127 (KIM-127), 10 mM
Mg21 plus 1 mM EGTA (Mg21/EGTA), and
50 nM PDBu. Cell adhesion assays were car-
ried out as specified in MATERIALS AND
METHODS. The results are the mean 6 SEM
of four independent experiments. (B) T lym-
phoblasts were plated either on ICAM-Fc–
coated dishes (ICAM-1) or on poly-l-lysine–
coated dishes (PLL) and stimulated as
indicated above. The cells were fixed, perme-
abilized, and stained with Texas Red–conju-
gated phalloidin. Immunofluorescence was
analyzed by confocal laser microscopy as de-
scribed in MATERIALS AND METHODS.
Arrows indicate the position of the cellular
extensions in representative polarized cells.
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Kinetics of Morphological Changes and Effects on T
Cell Motility of the Activation of LFA-1 Integrin
We used time-lapse digital video microscopy to inves-
tigate in detail the kinetics of the morphological
changes and the effects that these changes had on the
motility of lymphocytes after induction of activation
of the LFA-1 molecules. The kinetics of induction of
morphological changes was very similar for the three
different protocols of activation of LFA-1 used (Mg21-
EGTA, activating mAb KIM127, and PDBu). The
changes in cell morphology were already evident after
20 min, and after 60 min of induction of LFA-1 acti-
vation, .90% of T lymphoblasts displayed the char-
acteristic morphological features shown in Figure 1B.
The experiments of video microscopy also revealed
that induction of activation of LFA-1 on T lympho-
blasts adhering to ICAM-1 results in a switch from a
highly motile to a nonmotile phenotype (Figure 2). In
the arrested lymphoblasts, the cellular projection ex-
tending from the body of the cell seems to be firmly
anchored to the substrate, and only the cell body of the
lymphoblasts exhibited some lateral motility. Further-
more, quantitation of the distances traveled by the cell
bodies of individual lymphoblasts and their average
speeds in micrometers per hour confirmed that induc-
tion of activation of LFA-1 with PDBu, mAb KIM127,
or Mg21-EGTA results in a striking 13-fold reduction
in the motility of these cells, decreasing from almost
1700 mm/h (nonactivated) to 130 mm/h (activated
LFA-1) (Table 1).
Inhibition of Morphological Changes Induced by
Stimulation of LFA-1 by the Tyrosine Kinase
Inhibitor Genistein
To investigate whether tyrosine phosphorylation is
required for the observed changes in morphology and
level of adhesion of T lymphoblasts induced through
activation of LFA-1, we tested the effect of the specific
tyrosine kinase inhibitor genistein (Akiyama et al.,
1987). As observed in Figure 3A, the addition of
genistein at 30 mM to cells plated on dishes coated
with ICAM-1 and stimulated with mAb KIM-127 in-
hibited almost completely the morphological changes
induced by LFA-1, and the majority of cells remained
round shaped (Figure 3A). In contrast with its dra-
Figure 2. Lymphoblasts acquire a nonmotile phenotype after activation of integrin LFA-1. Lymphoblasts were allowed to bind on
ICAM-1-Fc–coated dishes and stimulated for 45 min with saline solution (CONTROL), 50 nM PDBu, 10 mg/ml mAb KIM-127, or 10 mM
Mg21 plus 1 mM EGTA (Mg21/EGTA) before filming. The movement of the lymphoblasts was recorded by time-lapse video microscopy for
0, 40, 80, 120, and 160 s. The trajectories of individual cells were analyzed, and representative migration tracks are shown.
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matic effects on lymphoblast morphology and polar-
ization, genistein did not affect significantly the adhe-
sion of these cells to ICAM-1 (Figure 3B). These results
suggest that tyrosine kinase activity is required for
LFA-1–induced changes in the morphology of lym-
phoblasts.
LFA-1 Stimulates FAK and PYK-2 Tyrosine Kinase
Activity in Human Lymphoblasts
Because a tyrosine kinase seemed to be involved in the
signaling from LFA-1, we examined the effect of stim-
ulation of LFA-1 on the tyrosine kinase activities
present in lymphoblasts. Cells plated on dishes coated
with ICAM-1 were treated with the activating mAb
KIM-127 for 30 min and lysed. Tyr(P) proteins were
immunoprecipitated from the cell lysates with the
mAb PY20, and the resulting immune complexes were
incubated with [g-32P]ATP, analyzed by SDS-PAGE,
and subjected to autoradiography. In the immunopre-
cipitates obtained from KIM-127–treated cells, we ob-
served strong phosphorylation of several bands in the
Mr 110,000–180,0000 and 70,000–80,000 ranges (Fig-
ure 4, left panel). Results identical to those shown in
Figure 4, left panel, were obtained when immunopre-
cipitates were prepared using a different anti-Tyr(P)
mAb (PY72).
To determine whether the tyrosine kinases FAK and
PYK-2 were among the Mr 110,000–180,000 bands in
the PY20 immune complexes, 32P-labeled Tyr(P)-pro-
teins obtained from parallel cell cultures, unstimu-
lated or treated for 30 min with KIM-127 mAb, were
eluted from the complexes by denaturation in the
presence of SDS and subsequently reimmunoprecipi-
tated either with the C-20 anti-FAK (FAK) or with the
C-19 anti-PYK-2 (PYK-2) polyclonal antibodies, or
with nonimmune rabbit serum (NIS; Figure 4) (or
nonimmune goat serum). C-20 and C-19 antibodies
are specific for the C-terminal region of FAK and
PYK-2, respectively (see MATERIALS AND METH-
ODS). The results obtained demonstrate that both
FAK and PYK-2 are constituents of the Mr 110,000–
180,000 Tyr(P) bands induced after activation of
LFA-1. At the percentage of SDS-PAGE used in this
experiment (8%), bands corresponding to FAK and
PYK-2 showed very similar electrophoretic mobilities,
but at lower SDS-PAGE percentages, PYK-2 migrated
at a slightly lower Mr compared with FAK (Earp et al.,
1995).
To confirm directly that LFA-1 stimulates FAK ac-
tivity, lysates of KIM-127–treated lymphoblasts were
incubated with the anti-FAK antibody C-20, and the
C-20 immunoprecipitates were incubated with
[g-32P]ATP and analyzed by SDS-PAGE. As observed
in Figure 5A (IP: C-20), FAK activity increases upon
KIM-127 stimulation. No kinase activity was detected
when the lysates were immunoprecipitated with non-
immune rabbit serum (Figure 5A, IP: NIS). To further
confirm that the radiolabeled 125-kDa band was FAK,
we eluted this band by denaturation and reprecipi-
tated the eluted proteins with the mAb a-FAK, an
antibody that recognizes an epitope in the kinase do-
main of FAK (Figure 5A, IP: C-20 and r-IP: a-FAK).
The reimmunoprecipitation of the 125-kDa radiola-
beled band in these experiments confirmed that it is
phosphorylated FAK (Figure 5A, IP: C-20 and r-IP:
a-FAK). No band was detected when the C-20 immu-
noprecipitate was reimmunoprecipitated with nonim-
mune rabbit serum (Figure 5A, IP: C-20 and r-IP: NIS).
A similar increase in FAK activity after in vitro kinase
assays was also observed when lysates of lympho-
blasts stimulated with KIM-127 were immunoprecipi-
tated with A-17, a polyclonal antibody that recognizes
an epitope in the N terminus of FAK (Figure 5A, IP:
A-17) or with mAb 2A7, an antibody reactive with the
C-terminal sequence of FAK. SDS-PAGE and fluorog-
raphy of FAK immunoprecipitates obtained from
[35S]methionine metabolically labeled cells prepared
in parallel with those used for the kinase assays veri-
fied that similar amounts of FAK were recovered be-
fore and after KIM-127 treatment (Figure 5A, ML:
35S-Met and IP: C-20).
Table 1. Quantitation of cell migration
Condition Cell 1 Cell 2 Cell 3 Cell 4 Cell 5 Cell 6 Cell 7 Mean 6 SD
Control 1476 1636 1584 1900 1768 1663 1636 1666 6 135
PDBu 120 136 145 129 134 148 116 132 6 11
KIM-127 116 125 143 148 143 137 130 134 6 10
Mg21-EGTA 129 146 140 127 116 119 128 129 6 9
T lymphoblasts were plated on ICAM-1-Fc–coated plastic dishes and allowed to adhere for 45 min in the presence of the indicated stimuli
before filming starts. Films of cells were generated from stacks of individual digital images (frames) taken every 20 s for 2 h in an Zeiss
Axiovert 135 video microscope using the IP-Lab-Spectrum software. The distances migrated by individual cells were quantitated using the
Cell Tracking software extension developed by Tim Hutton. Numbers represent average speeds of migration of individual cells over a 20-min
period in micrometers per hour.
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Quantitative densitometric scanning showed that
activation of LFA-1 induced by treatment of the T
lymphoblasts with mAb KIM-127 induced a 2.5- 6
0.4-fold (n 5 3) and 2.4- 6 0.4-fold (n 5 4) increase
in the phosphorylation of FAK in immunoprecipi-
tates obtained with the C-20 and A-17 polyclonal
antibodies, respectively (Figure 5B). An increase in
the activity of FAK after KIM-127 treatment of lym-
phoblasts cells was also demonstrated when lysates
from control and KIM-127–stimulated cells were im-
munoprecipitated with the C-20 antibody, and ki-
nase activity was determined by the ability of the
immunoprecipitates to phosphorylate exogenously
added substrate poly-Glu-Tyr (4:1) (Figure 5C).
To further investigate the stimulation of PYK-2
activity through LFA-1, lysates of KIM-127–treated
lymphoblasts were incubated with the C-19 anti-
PYK-2 polyclonal antibody. PYK-2 immunoprecipi-
tates were incubated with [g-32P]ATP and analyzed
by SDS-PAGE. As observed in Figure 6A, in contrast
Figure 3. Tyrosine kinase inhibitor genistein blocks KIM-127–
stimulated polarization of lymphoblasts. (A) Lymphoblasts were
washed in RPMI 1640 medium and then treated as follows: pre-
treated for 2 h with 0.3% DMSO and then plated on ICAM-1-Fc–
coated dishes for 60 min (CONTROL); pretreated for 2 h with 0.3%
DMSO, plated on ICAM-Fc–coated dishes, and stimulated for 60
min with 10 mg/ml mAb KIM-127 (KIM-127); and pretreated for 2 h
with 30 mM of genistein dissolved in DMSO, plated on ICAM-Fc–
coated dishes, and stimulated for 60 min with 10 mg/ml mAb
KIM-127 (KIM-127 1 GENISTEIN). Cells were fixed and stained
with 0.5% crystal violet in 20% methanol before photography. A
representative experiment is shown. (B) Quantification of the cell
adhesion assays represented in A was carried out as specified in
MATERIALS AND METHODS. The results are the mean 6 SEM of
three independent experiments.
Figure 4. Presence of FAK and PYK-2 in anti-Tyr(P) immunopre-
cipitates from T cells after activation of LFA-1. T lymphoblasts (50 3
106 cells) plated on ICAM-1-Fc–coated plastic dishes were allowed
to adhere for 30 min in the absence (2) or presence (1) of 10 mg/ml
mAb KIM-127. The cells were then lysed, the extracts were immu-
noprecipitated (IP) with the PY20 anti-Tyr(P) mAb [IP: Tyr(P)], and
kinase reactions were performed as described in MATERIALS AND
METHODS. In parallel cultures of lymphoblasts, which were al-
lowed to adhere to ICAM-1-Fc and stimulated or not with KIM-127
as above, after the kinase reactions were carried out, the major
Tyr(P)-labeled bands were eluted from the PY20 immunocomplexes
by boiling the pellet in 100 ml of a solution containing 10 mM Tris,
pH 7.4 and 1% SDS. Denatured Tyr(P) proteins were then reimmu-
noprecipitated (r-IP) with the anti-FAK C-20 to confirm the presence
of FAK [IP: Tyr(P) and r-IP: FAK], with the anti-PYK-2 C-19 to
confirm the presence of PYK-2 [IP: Tyr(P) and r-IP: PYK-2], or with
nonimmune rabbit serum control [IP: Tyr (P) and r-IP: NIS]. After
SDS-PAGE of PY20 immunoprecipitates and C-20 and C-19 reim-
munoprecipitates, gels were subjected to autoradiography to detect
total phosphotyrosines FAK and PYK-2, respectively. The position
of the major phosphorylated bands in the gel is indicated with
arrowheads. The FAK and PYK-2 position is indicated by an arrow.
Molecular mass markers (in kilodaltons) are shown on the left. The
results are representative of three independent experiments.
J.L. Rodrı´guez-Ferna´ndez et al.
Molecular Biology of the Cell1898
to FAK, PYK-2 shows relatively high basal activity
in unstimulated cells that is further increased upon
LFA-1 activation. No kinase activity was detected
when the lysates were immunoprecipitated with
nonimmune goat serum (Figure 6A, NIS). Immuno-
blotting with N-19 antibody or C-19 antibody of
PYK-2 immunoprecipitates prepared in parallel
with those used for the kinase assays verified that
similar amounts of PYK-2 were recovered after
KIM-127 treatment (Figure 6A, IP: C-19 and WB:
C-19). Densitometric scanning showed that KIM-127
induced a 7.5- 6 1.4-fold (n 5 5) increase in the
phosphorylation of PYK-2 (Figure 6B). Accordingly,
we also observed a strong increase in the ability of
PYK-2 immunoprecipitates to phosphorylate the ex-
ogenous substrate poly-Glu-Tyr (4:1) when cells
were stimulated with KIM-127 (Figure 6C). No in-
crease in FAK or PYK-2 phosphorylation was ob-
served when lymphoblasts plated on BSA or poly-
l-lysine were stimulated with 10 mg/ml mAb KIM-
127 or when the cells plated on ICAM-1 were
stimulated with 10 mg/ml control antibody. Taken
together, these results show that both FAK and
PYK-2 increased their tyrosine kinase activities
upon LFA-1 activation.
Time Course of LFA-1–stimulated FAK and PYK-2
Tyrosine Kinase Activities
To study in detail the kinetics of activation of FAK
and PYK-2, lymphoblasts plated on dishes coated
with ICAM-1 were treated with the activating mAb
KIM-127 for different times and lysed. The lysates
were incubated with C-20 and C-19 antibodies to
immunoprecipitate FAK and PYK-2, respectively.
The resulting immune complexes were incubated
with [g-32P]ATP, analyzed by SDS-PAGE, and sub-
jected to autoradiography. As observed in Figure 7,
A and B (upper panels), KIM-127 stimulates the
activity of FAK with a kinetics different from that
observed for PYK-2. The increase in the activity of
FAK reached a maximum within 45 min and re-
mained sustainedly at this maximal level for at least
60 min (Figure 7A, upper panel). In contrast, the
increase in PYK-2 activity reached a maximum 30
min after stimulation with KIM-127, decreasing at
longer times (Figure 7B, upper panel). SDS-PAGE
and fluorography of anti-FAK immunoprecipitates
of [35S]methionine-labeled cells (Figure 7A, lower
panel) and immunoblotting with C-19 antibody of
anti-PYK-2 immunoprecipitates (Figure 7B, lower
panel), prepared in parallel with those used for the
Figure 5. KIM-127 induces stim-
ulation of FAK tyrosine kinase ac-
tivity. (A) T lymphoblasts plated
on ICAM-1-Fc–coated plastic
dishes were allowed to adhere for
60 min in the absence (2) or pres-
ence (1) of 10 mg/ml mAb KIM-
127. The cells were then lysed, the
extracts were incubated with the
C-20 antibody (IP: C-20) or with
nonimmune rabbit serum control
(IP: NIS), and kinase reactions
were carried out as described in
MATERIALS AND METHODS.
In parallel cultures, after the ki-
nase reaction was performed, the
major 125-kDa labeled band was
eluted from the C-20 immuno-
complex by boiling the pellet in
100 ml of a solution containing 10
mM Tris, pH 7.4 and 1% SDS. De-
natured FAK was then reimmu-
noprecipitated with the mAb a-FAK to confirm that the labeled band was phosphorylated FAK (IP: C-20 and r-IP: a-FAK) or with nonimmune
serum control (IP: C-20 and r-IP: NIS). Lysates obtained from cells untreated or treated with KIM-127 were also immunoprecipitated with
the A-17 polyclonal antibody (IP: A-17) and then subjected to in vitro kinase reactions performed as described in MATERIALS AND
METHODS. FAK levels were determined by metabolic labeling of parallel cultures of cells with [35S]methionine (ML: 35S-Met) and
immunoprecipitation of the labeled extracts with the C-20 anti-FAK antibody (IP: C-20). The position of FAK is indicated by an arrow. (B)
Quantification by densitometric scanning of the effect of KIM-127 on FAK activity. FAK was immunoprecipitated with either C-20 (left panel)
or A-17 (right panel) antibodies as in A, and the in vitro kinase reactions were carried out as described in MATERIALS AND METHODS.
Values are the mean 6 SEM of three independent experiments and are expressed as fold stimulation above control. (C) In vitro kinase
reactions of the C-20 FAK immunoprecipitates were performed in the presence of the tyrosine kinase substrate poly-Glu-Tyr (4:1).
Phosphorylation of poly-Glu-Tyr (4:1) was carried out after a 15-min incubation with [g-32P]ATP as described in MATERIALS AND
METHODS. A representative experiment is shown.
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kinase assays, confirmed that similar amounts of
FAK and PYK-2 kinases were recovered after differ-
ent times of KIM-127 treatment.
FAK and PYK-2 Are Redistributed after Activation
of LFA-1 and Colocalize with the MTOC
To study further the possible role of FAK and PYK-2
in the morphological changes observed in lympho-
blasts, we examined the localization of these tyrosine
kinases in resting and stimulated cells. Lymphoblasts
plated on ICAM-1, unstimulated or treated with
Mg21-EGTA, were stained by double-labeling immu-
nofluorescence with either C-20 rabbit polyclonal anti-
FAK antibody or C-19 goat polyclonal anti-PYK-2 an-
tibody and with an anti-a-tubulin mAb, as described
in MATERIALS AND METHODS. In unstimulated
cells, FAK (Figure 8A; unstimulated, FAK) and PYK-2
(Figure 8B; unstimulated, PYK-2) exhibited a diffuse
distribution. Interestingly, in these cells, PYK-2 also
localized to the cell–cell contact area (Figure 8B, un-
stimulated, PYK-2), as reported by others (Sasaki et al.,
1995). In cells in which LFA-1 was activated, FAK
(Figure 8A; stimulated, FAK) and PYK-2 (Figure 8B;
stimulated, PYK-2) are redistributed mainly to the
region between the cell body and the stemming pro-
jection. Similar staining was observed with the poly-
clonal antibodies A-17 and N-19, which recognize se-
quences in the N-termini of FAK and PYK-2,
respectively. This characteristic staining was specific,
because it was not observed in cells labeled with con-
trol nonimmune rabbit [Figure 8A, stimulated, NIS
(rabbit)] or goat [Figure 8B; stimulated, NIS (goat)]
sera. Interestingly, costaining with an anti-a-tubulin
antibody showed that the location of FAK and PYK-2
in stimulated cells coincides with the position of the
Figure 6. KIM-127 induces stimulation of PYK-2 tyrosine kinase
activity. (A) T lymphoblasts plated on ICAM-1-Fc–coated plastic
dishes were allowed to adhere for 30 min in the absence (2) or
presence (1) of 10 mg/ml mAb KIM-127. The cells were then lysed,
the extracts were incubated with C-19 antibody to immunoprecipi-
tate PYK-2 (C-19) or with nonimmune goat serum as a control (NIS),
and kinase reactions were performed as described in MATERIALS
AND METHODS. PYK-2 levels were determined by immunopre-
cipitation (IP) with the C-19 anti-PYK-2 antibody and Western blot
analysis (WB) with C-19 anti PYK-2 antibody. The position of PYK-2
is indicated with an arrow. The results shown are representative of
seven independent experiments. (B) Quantification by densitomet-
ric scanning of the effect of KIM-127 on PYK-2 activity. PYK-2 was
immunoprecipitated with the C-19 antibody and an in vitro kinase
reaction carried out as described in MATERIALS AND METHODS.
Values are the mean 6 SEM of five independent experiments and
are expressed as fold stimulation above control. (C) In vitro kinase
reactions of the C-19 PYK-2 immunoprecipitates were performed in
the presence of the tyrosine kinase substrate poly-Glu-Tyr (4:1).
Phosphorylation of poly-Glu-Tyr (4:1) was carried out after a 15-min
incubation with [g-32P]ATP as described in MATERIALS AND
METHODS. A representative experiment is shown.
Figure 7. Time course of LFA-1–stimulated FAK and PYK-2 activ-
ities in lymphoblasts. T cells plated on ICAM-1-Fc–coated plastic
dishes were stimulated for the indicated times with 10 mg/ml mAb
KIM-127 and lysed. (A) Lysates were incubated with the C-20
antibody to immunoprecipitate FAK, and kinase activities in the
resulting immunoprecipitates were measured by in vitro kinase
reaction performed as described in MATERIALS AND METHODS
(IVK). FAK levels were determined in parallel cultures by metabol-
ically labeling the cells with [35S]methionine and immunoprecipita-
tion of the labeled extracts with the C-20 antibody (ML: 35S-Met and
IP: C-20). The position of FAK is indicated with an arrow. (B)
Lysates were incubated with the C-19 antibody to immunoprecipi-
tate PYK-2, and kinase activities in the resulting immunoprecipi-
tates were measured by in vitro kinase reactions (IVK). PYK-2
immunoprecipitates were also analyzed by SDS-PAGE, followed by
transfer to Immobilon membranes and Western blotting with anti-
PYK-2 antibodies (IP: C-19 and WB: C-19). A representative exper-
iment is shown. The position of PYK-2 is indicated with an arrow.
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MTOC in polarized lymphoblasts (Figure 8, A and B,
stimulated, a-tubulin). Similar results were obtained
when single immunofluorescences for FAK, PYK-2, or
a-tubulin were performed, ruling out cross-detection
of fluorescence.
Actin and Microtubular Cytoskeletal Networks Are
Involved in the Morphological Changes Induced by
Stimulation of LFA-1
To evaluate the importance of cytoskeletal integrity in
the observed changes in cell morphology that take
place in lymphoblasts upon stimulation of activation
of LFA-1, we studied the effect of different cytoskeletal
perturbing agents in this process. Lymphoblasts were
pretreated with cytochalasin D (2.5 mM), a drug which
disrupts the actin cytoskeleton, colchicine (10 mM), or
taxol (1 mM), drugs that disrupt and stabilize the
tubulin cytoskeleton, respectively, and the cultures
were subsequently stimulated with the mAb KIM-127.
At the concentrations used, all the agents exerted only
a slight inhibitory effect on the adhesion of lympho-
blasts to ICAM-1. However, as shown in Figure 9A,
treatment with all these agents blocked the morpho-
logical changes in response to the stimulation with
KIM-127.
The changes in morphology observed in lympho-
blasts upon stimulation of activation of LFA-1 take
place concomitantly with a redistribution of FAK and
PYK-2 to the MTOC (Figure 8, A and B). We per-
formed immunofluorescence experiments to study
whether treatment with cytochalasin D or colchicine
had any effect on the distribution of FAK and PYK-2.
Figure 8. FAK and PYK-2 colocalize with the MTOC in polarized lymphoblasts. Lymphoblasts were allowed to adhere onto ICAM-1-Fc–
coated dishes for 60 min either in HEPES-NaCl buffer containing 1 mM Mg21 and 1 mM Ca21 (unstimulated) or in HEPES-NaCl containing
10 mM Mg21 and 1 mM EGTA (stimulated). (A) The cells were fixed, permeabilized, and double stained with C-20 rabbit polyclonal antibody
against FAK (FAK) or with a control rabbit nonimmune serum (NIS rabbit) and with an anti-a-tubulin mAb (a-tubulin) as specified in
MATERIALS AND METHODS. (B) The cells were fixed, permeabilized, and doubled stained with C-19 goat polyclonal antibody against
PYK-2 (C-19) or with a control goat nonimmune serum (NIS goat) and with an anti-a-tubulin mAb (a-tubulin) as specified in MATERIALS
AND METHODS. Arrowheads indicate the positions of the MTOC in representative cells.
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Figure 9. Cytoskeletal interfering agents block LFA-1–dependent
polarization of lymphoblasts and reduce translocation of FAK and
PYK-2 to the MTOC. (A) T Lymphoblasts were washed in RPMI
1640 medium and then pretreated for 4 h with 0.3% DMSO (KIM-
127), with 2.5 mM cytochalasin D dissolved in DMSO (KIM-127 1
CYT D), with 10 mM colchicine dissolved in DMSO (KIM-127 1
COLCH), or with 1 mM taxol dissolved in DMSO (KIM-127 1
TAXOL). Cells were subsequently plated on ICAM-Fc–coated
dishes and stimulated for 60 min with 10 mg/ml mAb KIM-127.
Attached cells were fixed and stained with 0.5% crystal violet in 20%
methanol before photography. A representative experiment is
shown. (B and C) T Lymphoblasts were washed in RPMI medium
and then pretreated for 4 h with 0.3% DMSO (stimulated), with 2.5
mM cytochalasin D (stimulated 1 CYT D), or with 10 mM colchicine
(stimulated 1 COLCH). After this pretreatment, cells were washed
in HEPES-NaCl buffer, plated on ICAM-1-Fc–coated dishes, and
stimulated for 60 min with 10 mM Mg21 plus 1 mM EGTA. The cells
were fixed, permeabilized, and doubled stained with C-20 rabbit
polyclonal antibody against FAK (B, FAK) or with C-19 goat poly-
clonal antibody against PYK-2 (C, PYK-2) and with an anti-a-tubu-
lin mAb (B and C, a-tubulin). Immunofluorescence samples were
analyzed by confocal laser microscopy as specified in MATERIALS
AND METHODS. Arrowheads indicate the position of the MTOC.
A representative experiment is shown.
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For this purpose, lymphoblasts were pretreated either
with vehicle DMSO (Figure 9, B and C, stimulated),
cytochalasin D (Figure 9, B and C, stimulated 1 CYT
D), or colchicine (Figure 9, B and C, stimulated 1
COLCH), and the cultures were subsequently stimu-
lated with Mg21-EGTA to stimulate LFA-1. In contrast
with cells pretreated with DMSO, which display a
highly polarized morphology, with long cellular pro-
jections and the characteristic staining of FAK and
PYK-2 colocalizing with the MTOC (Figure 9, B and C,
stimulated), cytochalasin D-treated (Figure 9, B and C,
stimulated 1 CYT D) and colchicine-treated cells (Fig-
ure 9, B and C, stimulated 1 COLCH) showed a
rounded morphology. Interestingly, in the cytochala-
sin D- and colchicine-treated cells some FAK and
PYK-2 staining remained colocalizing with the MTOC,
but the intensity of this staining was lower in compar-
ison with control cells (Figure 9, B and C).
LFA-1–mediated Activation of FAK and PYK-2
Requires Cytoskeletal Integrity
Because cytoskeletal disrupting agents affect the relo-
cation of FAK and PYK-2 to the MTOC in lympho-
blasts, we also studied the effect of these agents on the
activation of FAK and PYK-2. For this purpose, lym-
phoblasts were pretreated with cytochalasin D (2.5
mM), colchicine (10 mM), or taxol (1 mM). The cells
were subsequently plated on dishes coated with
ICAM-1 and treated with the activating mAb KIM-
127. As shown in Figure 10, A and B (upper panels), all
the agents blocked the increase in FAK and PYK-2
activity in response to the stimulation of LFA-1. Taken
together, these results suggest that the reorganization
of the actin and tubulin networks that takes place after
stimulation of LFA-1 is required for FAK and PYK-2
activation.
DISCUSSION
Polarization of T lymphocytes upon interaction with
APCs or during chemokine directed transendothelial
migration is a relevant phenomenon that is thought to
contribute importantly to the specificity and effective-
ness of immune responses (Geiger et al., 1982; del Pozo
et al., 1996; Sa´nchez-Madrid and del Pozo, 1999). Cell
polarization involves the conversion from a spherical
to an elongated morphology, a process in which im-
portant changes in the organization of the cytoskele-
ton take place. In the present study we report that
upon induction of activation of the b2-integrin LFA-1,
T lymphocytes undergo a dramatic polarization, char-
acterized by the conversion from a spherical morphol-
ogy, characteristic of the nonadherent cells, to an elon-
gated morphology, characterized by the presence of a
cell body and a long cellular extension. These morpho-
logical changes take place as a result of the interaction
between activated LFA-1 integrin molecules with li-
gand ICAM-1, because they are not observed when
cells are plated on poly-l-lysine. The induction of
activation of the LFA-1 integrin on T lymphoblasts
adhering to ICAM-1 also involves the conversion of
the cells from a highly motile to a nonmotile pheno-
type. Furthermore, we demonstrate that binding of T
lymphoblasts to the LFA-1 ligand ICAM-1 induces the
activation and intracellular redistribution of the ty-
rosine kinases FAK and PYK-2.
The described changes in the adhesive capacity,
morphology, and locomotive behavior in T lympho-
blasts upon induction of activation of LFA-1 mole-
cules take place using three different protocols for
Figure 10. Cytoskeletal interfering agents block LFA-1–dependent
increase in FAK and PYK-2 kinase activities. (A) T Lymphoblasts
were washed in RPMI 1640 medium and then pretreated for 4 h
with 0.3% DMSO (CONTROL), with 2.5 mM cytochalasin D dis-
solved in DMSO (CYT D), with 10 mM colchicine dissolved in
DMSO (COLCH), or with 1 mM taxol dissolved in DMSO (TAXOL).
T cells were subsequently plated onto ICAM-1-Fc–coated dishes
and allowed to adhere for 60 min in the absence (2) or presence (1)
of 10 mg/ml mAb KIM-127. Cells were lysed, and lysates were
incubated with the C-20 antibody to immunoprecipitate FAK. Ki-
nase activities in the resulting immunoprecipitates were measured
by in vitro kinase reactions performed as described in MATERIALS
AND METHODS (IVK, top). FAK levels were determined in parallel
cultures by metabolic labeling the cells with [35S]methionine and
immunoprecipitation of the labeled extracts with C-20 antibody
(ML: 35S-Met and IP: C-20, bottom). The position of FAK is indicated
with an arrow. (B) T Lymphoblasts were pretreated as in A in the
presence of DMSO (CONTROL), cytochalasin D (CYT D), colchicine
(COLCH), or (TAXOL). T cells were subsequently plated onto
ICAM-1-Fc–coated dishes and allowed to adhere for 30 min in the
absence (2) or presence (1) of 10 mg/ml mAb KIM-127. Cells were
then lysed, and half of the lysates were incubated with C-19 anti-
body to immunoprecipitate PYK-2 and kinase reactions performed
as described in MATERIALS AND METHODS (IVK, top). The other
half of the lysates were also immunoprecipitated with C-19 anti-
body and analyzed by SDS-PAGE, followed by transfer of proteins
to Immobilon membranes and Western blotting with anti-PYK-2
antibodies (IP: C-19 and WB: C-19, bottom). The position of PYK-2
is indicated with an arrow.
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induction of activation of LFA-1 molecules, i.e., 1) the
presence in the medium of divalent cation Mg21, 2)
incubation of cells with the b2-specific stimulatory
mAb KIM-127, and 3) the addition of the phorbol ester
PDBu. Interestingly, the first two protocols of induc-
tion of LFA-1 activation have been reported to affect
mainly the affinity of this integrin, whereas the treat-
ment with phorbol esters induces integrin adhesive
capacity primarily through changes in avidity (Stew-
art et al., 1996). In parallel with the polarized morphol-
ogy, we observed that the lymphocytes acquire a non-
motile phenotype. The cell polarization and the arrest
of the migrating T lymphocytes seem to be related
phenomena, which contribute to the proper function
of T lymphocytes. Thus, after T cell antigen receptor
engagement during interaction with APCs, a stop sig-
nal is delivered through LFA-1 that converts the mi-
grating T lymphocytes into nonmotile cells. This pro-
cess appears to be an important requisite for an
adequate immune response (Dustin et al., 1997; Lowin-
Kropf et al., 1998).
To study whether a tyrosine kinase activity was
required for the observed LFA-1–mediated increase in
T cell adhesion and polarization, we used the specific
tyrosine kinase inhibitor genistein. Pretreatment with
genistein blocked the polarization of the lymphoblasts
with mAb KIM-127, suggesting that the morphologi-
cal changes induced through the integrin LFA-1 re-
quire a tyrosine kinase activity. Genistein, however,
had no significant effect on the adhesion of these cells
to ICAM-1. Because in these experiments we used the
mAb KIM-127 to activate the integrin LFA-1, these
results suggest either that adhesion mediated by
LFA-1 in lymphoblasts does not require a genistein-
sensitive tyrosine kinase activity and/or that the af-
finity of LFA-1 for ligand ICAM-1 that is induced by
KIM-127 treatment is high enough to maintain the
cells strongly adhered, even when tyrosine kinases are
inhibited.
We demonstrate for the first time that upon activa-
tion of LFA-1 and binding of T lymphocytes to ligand
ICAM-1, the two related nonreceptor tyrosine kinases
FAK and PYK-2 become activated. FAK and PYK-2
immunoprecipitates possess intrinsic autokinase ac-
tivities and are able to phosphorylate exogenous sub-
strates, such as the tyrosine kinase substrate poly-Glu-
Tyr (4:1). Because several studies have demonstrated
that the major phosphorylation sites on FAK and
PYK-2 (i.e., Tyr-397 and Tyr-402, respectively) are
high-affinity binding sites for the SH2 domain of mem-
bers of the Src kinase family (Richardson and Parsons,
1995), and Src members are able to phosphorylate
FAK, it has been suggested that FAK and PYK-2 ki-
nase activities could also reflect the presence of Src in
the immunoprecipitates, rather than an intrinsic in-
crease in their activities. Nevertheless, several lines of
evidence indicate that this is not the case in our assays.
First, in the lysis buffer in which our experiments were
carried out, which contains the nonionic detergent
Triton X-100 (see MATERIALS AND METHODS), the
interaction between Src and FAK is minimal (Rodrı´-
guez-Ferna´ndez and Rozengurt, 1998; Schlaepfer et al.,
1998). Second, when we used in our in vitro phosphor-
ylation assays pyrazolopyrimidine, a novel specific
inhibitor of Src kinases, we did not observe any inhi-
bition in FAK activity at concentrations that virtually
abolished Src kinase activity in parallel Src immuno-
precipitates (Rodrı´guez-Ferna´ndez and Rozengurt,
1998). Therefore, the previous results strongly suggest
that the increases in FAK and PYK-2 tyrosine kinases
induced upon activation of integrin LFA-1 cannot be
attributed to the presence of Src in the immunopre-
cipitates.
Several groups have shown that in leukocytes and
other cells FAK and PYK-2 become tyrosine phosphor-
ylated and activated upon stimulation of members of
the b1, b3, and b5 family of integrins (Kornberg et al.,
1991; Guan and Shalloway, 1992; Hanks et al., 1992;
Lipfert et al., 1992; Schaller et al., 1992; Shattil et al.,
1994; Maguire et al., 1995; Li et al., 1996; Astier et al.,
1997; Gismondi et al., 1997; Ma et al., 1997). Further-
more, it has been shown that fakB, a putative homo-
logue of FAK present in lymphocytes, is regulated by
the b2-integrin LFA-1 (Kanner et al., 1994; Kanner,
1996). However, to our knowledge there are no reports
demonstrating activation of FAK and/or PYK-2 upon
engagement of a member of the b2 family of integrins.
Although the precise mechanism by which integrins
are able to activate FAK or PYK-2 is not known, the
N-terminal region of FAK has been shown to associate
in vitro with peptides corresponding to cytoplamic
segments of b1-, b2-, and b3-integrin subunits
(Schaller et al., 1995). It has been speculated that the
direct interaction with the cytoplasmic domain of the
integrins could contribute to the activation of FAK
(Schaller et al., 1995).
In polarized T lymphoblasts the activation of FAK
and PYK-2 occurs in parallel with a redistribution of
these kinases from a relatively diffuse localization in
the cytoplasm to a location close to or in association
with the MTOC of the lymphocytes. The MTOC is a
critical organizing point within the cell, which be-
comes reoriented during cell polarization, and is
thought to participate in the redistribution and con-
centration of surface molecules in membrane caps,
including different adhesion receptors (Dustin et al.,
1997; Sa´nchez-Madrid and del Pozo, 1999). Further-
more, several studies have suggested that the MTOC
helps position the T cell secretory apparatus. For ex-
ample, it was observed that reorientation of the MTOC
was followed by the polarized concentration of cyto-
kines and cytotoxic mediators at the T cell–APC sur-
face (Kupfer et al., 1991).
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It has been reported that engagement of T cell re-
ceptor by physiological ligands delivers a stop signal
to lymphocytes migrating on purified ligand ICAM-1
(Dustin et al., 1997). In these experiments, it was ob-
served that the MTOC was repositioned to a location
adjacent to the site of stable lymphocyte anchorage,
suggesting that the MTOC in the arrested cells could
have a role in maintaining the nonmotile phenotype of
these cells. We observe in our immunofluorescence
and video microscopy experiments that the MTOC in
polarized lymphocytes is consistently found at a spe-
cific cytoplasmic location, in the region between the
cell body and the long cellular extension, which is
characterized by strong anchorage to the substrate
ICAM-1. These results concur with two recent reports
describing that the MTOC localizes to the distal por-
tion of the posterior appendage known as uropod in
polarized migrating lymphocytes (Ratner et al., 1997;
Serrador et al., 1997). Furthermore, it has been re-
ported that activation of human T lymphocytes in-
duces tyrosine phosphorylation of a-tubulin (Ley et
al., 1994; Marie-Cardine et al., 1995). Interestingly,
LFA-1–induced activation of PYK-2 was blocked by
pretreatment of the cells with agents that interfere
with actin and tubulin components of cytoskeleton,
suggesting that PYK-2 activation requires cytoskeletal
integrity to allow the activation of this enzyme. It is
noteworthy that in other systems FAK and PYK-2
activation is blocked with agents that affect actin, but
not tubulin, polymerization (Sinnett-Smith et al., 1993;
Astier et al., 1997; Rodrı´guez-Ferna´ndez et al., 1998).
In conclusion, in this study we demonstrate that the
interaction between activated integrin LFA-1 and its
ligand ICAM-1 leads to changes in cell morphology
and to the acquisition of a nonmotile phenotype of T
lymphocytes. We show, for the first time, that concom-
itant with these changes, LFA-1 induces activation of
the cytoplasmic tyrosine kinases FAK and PYK-2 and
redistribution of both kinases to a region close to the
MTOC.
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